Zydus Cadila gets US FDA nod to market anti-obesity drug EP News Bureau Jun 30, 2017 The drug will be produced at the group’s formulations manufacturing facility at Moraiya in Ahmedabad
Zydus Cadila to market oxybutynin chloride tablets EP News Bureau Jun 28, 2017 Oxybutynin is used to treat overactive bladder and urinary incontinence
Zydus receives US FDA approval for Glyburide and Metformin Hcl tabs Usha Sharma Mar 2, 2016 The formulations manufacturing facility at Baddi will produce the drug for the US market
Mankind Pharma launches anti-diabetic product Dynaglipt Sanjiv Das Nov 24, 2015 Zydus Cadila also launches its generic Tenglyn tablets, Gliptins, in the Indian market for Rs 7 per tablet Mankind Pharma has…
Zydus launches Adalimuma EP News Bureau Dec 22, 2014 Zydus Cadila announced the launch of its biosimilar Adalimumab, following an approval from the Drug Controller General (India)
Zydus launches world’s first biosimilar of Adalimumab EP News Bureau Dec 9, 2014 Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis, juvenile…